VALD, a global health technology company and the system of choice for musculoskeletal (MSK) health professionals announced a significant growth equity investment from FTV Capital, a sector-focused growth equity firm. This investment will enable VALD to grow its global team into new markets, launch new product offerings and capabilities, and continue to utilize AI to create unique applications for the company’s proprietary dataset of tens of millions of MSK health records.
MSK health has been a historically underserved yet vast market. However, it has been characterized by excessive costs and procedures, inefficient pen-and-paper workflows, and poor outcomes.
VALD tackles these issues by delivering a comprehensive suite of MSK technologies that enable health, performance, and tactical clinicians – ranging from small physical therapy and athletic training practices to larger health systems, professional sports teams, leagues, tactical operators, etc. to enhance diagnostic capabilities and capture real-time data. By assessing strength, balance, movement, speed, etc., VALD offers advanced tools previously confined to laboratories.
Since being founded in 2015, VALD has demonstrated market-leading growth with revenue more than tripling since 2021, staff in over 30 countries, and a dataset of MSK records roughly doubling yearly. And VALD serves global blue-chip customers, including over 75% of all major league sports franchises (e.g., NFL, NBA, MLB, NHL and MLS), over 90 percent of Power 5 NCAA colleges, 20 Premier League teams, the U.S. Olympic Team, branches of the U.S. military and thousands of leading health systems and clinics.
As part of the growth investment, Alex Mason and Justin Levine, vice president at FTV Capital, joined VALD’s board of directors.
KEY QUOTES:
“Over the past decade, we’ve been able to achieve rapid growth as a first mover in our industry, while the market still remains largely untapped. Our fully integrated suite of products, software solutions, and proprietary data empowers our customers to increase efficiencies within their workflows and ultimately improve their standard of care and patient outcomes. FTV brings an unmatched network of investors and advisors, as well as an intimate knowledge of the MSK industry, which are vital to capturing the massive opportunity in front of us and, more importantly, helping millions of patients, athletes, and tactical operators around the world suffering from MSK conditions.”
-Laurie Malone, CEO and co-founder of VALD
“While demand for MSK health services is outpacing other conditions globally, the market is still in the early innings of its digital transformation. VALD’s end-to-end offering is viewed as mission critical by thousands of organizations who rely on its interactive, software-enabled platform to help measure, manage and improve human performance and mobility. We are excited to partner with Laurie and the VALD management team to help usher the company through its next phase of growth and reinforce its dominant position in the market.”
-Alex Mason, partner at FTV Capital
